Survivor’s story foreshadows one of oncology’s greatest successesApril 14, 2022Hodgkin LymphomaTransplantCLL
Repurposed drug could revolutionize stem cell transplantationMarch 18, 2022TransplantB Cell LymphomaHodgkin LymphomaMultiple MyelomaPediatricsDLBCLCLL
100 coauthored papers, 10 years: Cancer transplant pioneers model 'team science'January 21, 2022TransplantAggressive LymphomasALLDLBCLCLLTranslational ResearchB Cell Lymphoma
DKMS: Small nonprofit to world’s largest stem cell donor registryJanuary 21, 2022ALLCOVID-19 UpdatesMixed TopicsMultiple MyelomaDLBCLB Cell LymphomaAML
Poor survival with COVID in patients who have had HSCTMarch 26, 2021CMLTransplantALLDLBCLB Cell Lymphoma
Allo-HSCT plus monoclonal antibody treatment can improve survival in patients with r/r B-ALLMarch 24, 2021TransplantALL
Omidubicel improves on umbilical cord blood transplantsMarch 22, 2021TransplantALLAMLCMLMyelodysplastic SyndromeB Cell Lymphoma
Maribavir seen as superior to other antivirals for CMV clearance post transplantMarch 4, 2021TransplantAML
Using engineered T cells reduced acute, chronic GVHDFebruary 23, 2021TransplantALLAMLB Cell LymphomaMyelodysplastic SyndromeCellular Therapy
Steroid complications in GVHD common, boost costs of careFebruary 19, 2021TransplantALLMultiple MyelomaDLBCLB Cell Lymphoma
